[Which patient for TAVI in 2019?]
| Autor: | CAYLA, G., Schmutz, L., Soullier, C., Ricci, J.E., Robert, Cédric, Cambon-Viala, M., Goger, A.L., Lattuca, B. |
|---|---|
| Přispěvatelé: | Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Université de Montpellier (UM) |
| Jazyk: | francouzština |
| Rok vydání: | 2019 |
| Předmět: |
Heart Valve Prosthesis Implantation
Reoperation Patient Selection Aortic stenosis Heart team Aortic Valve Stenosis Rétrécissement aortique Transcatheter valve implantation Risk Assessment Prosthesis Failure Contraindications Procedure Transcatheter Aortic Valve Replacement TAVI Valve aortique percutanée [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system Aortic Valve Heart Valve Prosthesis Practice Guidelines as Topic Humans Indications |
| Zdroj: | Annales de Cardiologie et d'Angéiologie Annales de Cardiologie et d'Angéiologie, Elsevier Masson, 2019, 68 (6), pp.405-409. ⟨10.1016/j.ancard.2019.10.002⟩ |
| ISSN: | 0003-3928 1768-3181 |
| DOI: | 10.1016/j.ancard.2019.10.002⟩ |
| Popis: | International audience; The therapeutic management of aortic stenosis has been drastically changed by the advent of percutaneous valve replacement (TAVI). Since the first implantation, the indications have progressively been extended from the inoperable patient to the patient at low surgical risk. The main objective of this review is to describe the currently recommended main indications of TAVI depending on an individualized assessment of each patient's risk, technical characteristics and anatomical valvular criteria. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect